Allos AI today announced $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry's ...
Earlier on Wednesday, Laekna, “a global biotech company focused on novel drug development for metabolic and cancer diseases,” accoding to its release, announced a clinical collaboration with Eli Lilly ...
Alzheimer's Drug Discovery Foundation Invests in First-of-its-Kind Biomarker Observatory Led by Renowned Clinical Trials Expert to Accelerate Novel Drug Development PR Newswire NEW YORK, Sept. 18, ...
The pharmaceutical industry is constantly in flux, with legal directives, increasing costs, and political unease all contributing to an unsettling financial environment. Discoveries, innovations, ...
Ahmedabad: The Indian pharmaceutical industry needs to transition from a volume-driven generic model to a value-led ...
LOS ANGELES--(BUSINESS WIRE)--Laekna, Inc. (2105.HK) (“Laekna”), a global biotech company focused on novel drug development for metabolic and cancer diseases, is pleased to announce a clinical ...
VANCOUVER, BC / ACCESS Newswire / April 14, 2025 / Lobe Sciences Ltd. ("Lobe Sciences" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F) a commercial stage biopharmaceutical company focused on ...
Led by Dr. Jeffrey Cummings, the Observatory will enable broader access to the biomarker pipeline, accelerating the development of novel drugs that will be used in combination with available drugs on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results